Possible role of matrix metalloproteinases in reconstruction of peripheral pulmonary arteries induced by hypoxia

Physiological Research

Volumn 51, Issue 4, 2002, Pages 323-334

  Novotna J ^a,b   Herget, Jan ^a,b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Ctr for Exp Cardiovasc Research   (Czech Republic)

Author keywords

Chronic hypoxia; Collagen; Hypoxic pulmonary hypertension; Metalloproteinases; Vascular remodeling

Indexed keywords

COLLAGEN FIBRIL; COLLAGENASE; COLLAGENASE 3; GELATINASE A; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 16; MATRIX METALLOPROTEINASE 17; MATRIX METALLOPROTEINASE 18; MATRIX METALLOPROTEINASE 19; MATRIX METALLOPROTEINASE 20; MATRIX METALLOPROTEINASE 21; MATRIX METALLOPROTEINASE 22; MATRIX METALLOPROTEINASE 23; MATRIX METALLOPROTEINASE 24; MATRIX METALLOPROTEINASE 25; MATRIX METALLOPROTEINASE 26; MATRIX METALLOPROTEINASE 27; MATRIX METALLOPROTEINASE 28; NEUTROPHIL COLLAGENASE; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3; UNCLASSIFIED DRUG;

CELL ULTRASTRUCTURE; CELL WALL; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; ENZYME ACTIVATION; HYPOXIA; MESENCHYME; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; PULMONARY HYPERTENSION; SHORT SURVEY; SIGNAL TRANSDUCTION; TURNOVER TIME;

ANIMALS; ANOXIA; CHRONIC DISEASE; COLLAGEN; EXTRACELLULAR MATRIX; HUMANS; MATRIX METALLOPROTEINASES; PULMONARY ARTERY;

EID: 0036404525     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (83)

1. Bačáková L, Herget J, Wilhelm J: Influence of macrophages and macrophage-modified collagen I on the adhesion and proliferation of vascular smooth muscle cells in culture, Physiol Res 48: 341-351, 1999.
2. Bačaková L, Lisá V, Kubínová L, Wilhelm J, Novotná J, Eckhardt A, Herget J: UV light-irradiated collagen III modulates expression of cytoskeletal and surface adhesion molecules in rat aortic smooth muscle in vitro. Virchows Arch 440: 50-62, 2002.
3. Bačákova L, Wilhelm J, Herget J, Novotná J, Eckhart A: Oxidized collagen stimulates proliferation of vascular smooth muscle cells. Exp Mol Pathol 64: 185-194, 1997.
4. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am J Physiol 271: C1424-C1437, 1996.
5. 2 exposure. Lab Invest 77: 533-539, 1997.
6. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA: Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 75: 539-545, 1994.
7. Brown JC, Timpl R: The collagen superfamily. Int Arch Allergy Immunol 107: 484-490, 1995.
8. Butler GS, Hutton M, Wattam BA, Williamson RA, Knauper V, Willenbrock F, Murphy G: The specificity of TIMP-2 for matrix metalloproteinases can be modified by single amino acid mutations. J Biol Chem 274: 20391-20396, 1999.
9. Chen S, Cohen MP, Lautenslager GT, Shearman CW, Ziyadeh FN: Glycated albumin stimulates TGF-beta 1 production and protein kinase C activity in glomerular endothelial cells, Kidney Int 59: 673-681, 2001.
10. Cho A, Graves J, Reidy MA: Mitogen activated protein kinase matrix metalloproteinase-9 expression in vascular smooth muscle. Arteroscler Thromb Vasc Biol 20: 2257-2532, 2000.
11. Coats WD Jr., Faxon DP: The role of the extracellular matrix in arterial remodelling. Semin Interv Cardiol 2: 167-176, 1997.
12. Cowell S, Knauper V, Stewart ML, D'Ortho MP, Stanton H, Hembry RM, Lopez-Otin C, Reynolds JJ, Murphy G: Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: Associated activation of gelatinase A, gelatinase B and collagenase 3. Biochem J 331: 453-458, 1998.
13. De Souza SJ, Pereira H.M, Jacchieri S, Brentani RR: Collagen/collagenase interaction: Does the enzyme mimic the conformation of its own substrate? FASEB J 10: 927-930, 1996.
14. Deyl Z, Novotná J, Mikšík I, Herget J.: Micropreparation of tissue collagenase fragments of type I collagen in the form of surfactant-peptide complexes and their identification by capillary electrophoresis and partial sequencing. J Chromatogr A 796: 181-193, 1998.
15. Emonard H, Grimoud JA: Matrix metalloproteinases. A review. Cell Mol Biol 36: 131-153, 1990.
16. Fang J, Shing Y, Wiederschain D, Yan L, Butterfield C, Jackson G, Harper J, Tamvakopoulos G, Moses MA: Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci USA 97: 3884-3889, 2000.
17. Faxon DP, Borst C.: Remodelling: Historical perspectives and definition of terms. Semin Interv Cardiol 2: 145-146, 1997.
18. Frears ER, Zhang Z, Blake DR, O'Connell JP, Winyard PG: Inactivation of tissue inhibitor of metalloproteinase-1 by peroxynitrite. FEBS Lett 381: 21-24, 1996.
19. Gardi C, Pacini A, De Santi MM, Calzoni P, Viti A, Corradeschi F: Development of interstitial lung fibrosis by long-term treatment with collagen breakdown products in rabbits. Res Commun Chem Pathol Pharmacol 68: 238-250, 1990.
20. Gardi D, Calzoni P, Marcolongo P, Vavarra E, Vanni L, Lungarella G: Collagen breakdown and lung collagen metabolism: An in vitro study on fibroblast cultures. Thorax 49: 312-318, 1994.
21. Gomez DE, Alonso DF, Yoshiji H, Thorgiersson UP: Tissue inhibitors of metalloproteinases: Structure, regulation, and biological function. Eur J Cell Biol 74: 267-274, 1997.
22. Greenwald RA, Woessner JF: Common names of matrix metalloproteinases. In: Inhibition of Matrix Metalloproteinases: Therapeutic Applications. RA Greenwald, S Zucker, LM Golub (eds), The New York Academy of Science, New York, 1999, pp xix.
23. Hampl V, Herget J: Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension. Physiol Rev 80: 1337-1384, 2000.
24. Heath D, Kay JM: Medial thickness of pulmonary trunk in rats with cor pulmonale induced by ingestion of Crotalaria spectabilis seeds. Cardiovasc Res 1: 74-79, 1967.
25. Herget J, Suggett AJ, Leach E, Barer GR: Resolution of pulmonary hypertension and other features induced by chronic hypoxia in rats during complete and intermittent normoxia. Thorax 33: 468-473, 1978.
26. Herget J, Wilhelm J, Novotná J, Eckhardt A, Vytášek R, Mrázková L, Ošťádal M: A possible role of oxidant tissue injury in the development of pulmonary hypertension. Physiol Res 49: 493-501, 2000.
27. Illman S.A, Keski-Oja J, Lohl J: Promotor characterization of the human and mouse epilysin (MMP-28) genes. Gene 275: 185-194, 2001.
28. Jackson CJ, Nguyen M: Human microvascular endothelial cells differ from macrovascular endothelial cells in their expression of matrix metalloproteinases. Int J Biochem Cell Biol 29: 1167-1177, 1997.
29. Johnson JL, Jackson CL, Angelini GD, George SJ: Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 18: 1707-1715, 1998.
30. Kehrel B: Platelet-collagen interactions. Semin Thromb Hemost 21: 123-129, 1995.
31. Kenagy RD, Vergel S, Mattsson E, Bendeck M, Reidy MA, Clowes AW: The role of plasminogen, plasminogen activators, and matrix metalloproteinases in primate arterial smooth muscle cell migration. Arterioscler Thromb Vasc Biol 16: 1373-1382, 1996.
32. Kivirikko KI, Myllyla R: Biosynthesis of collagens. In Extracellular Matrix Biochemistry. KH Pietz, AH Reddi (eds). Elsevier, New York, 1984, vol. 20, pp 137-152.
33. Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G: Biochemical characterization of human collagenase-3. J Biol Chem 271: 1544-1550, 1996a.
34. Knauper V, Will H, Lopez-Otin C, Smith B, Atkinson SJ, Stanton H, Hembry RM, Murphy G: Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 271: 17124-17131, 1996b.
35. Knauper V, Cowell S, Smith B, Lopez-Otin C, O'Shea M, Morris H, Zardi L, Murphy G: The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 272: 7608-7616, 1997a.
36. Knauper V, Smith B, Lopez-Otin C, Murphy G: Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13). Eur J Biochem 248: 369-373, 1997b.
37. Kojima S, Yoshifumi I, Matsumoto S, Masuho Y, Seiki M: Membrane-type 6 matrix metalloproteinase (MT6-MMP, MMP-25) is the second glycosyl-phosphatidyl inositol (GPI)-anchored MMP. FEBS Lett 480: 142-146, 2000.
38. Krane SM, Byrne MH, Lemaitre V, Henriet P, Jeffrey JJ, Witter JP, Liu X, Wu H, Jaenisch R, Eeckhout Y: Different collagenase gene products have different roles in degradation of type I collagen. J Biol Chem 271: 28509-28515, 1996.
39. Kranzhofer A, Baker AH, George SJ, Newby AC: Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous vein. Arterioscler Thromb Vasc Biol 19: 255-265, 1999.
40. Laurent GJ, Bishop JE, Gray A, Peacock A, Harrison NK, Winlove CP, Lever MJ, Reeves JT: Deposition of arterial collagen in pulmonary hypertension. In Pulmonary Blood Vessels in Lung Disease. J Widimský, J Herget (eds), Prog Respir Res, Karger, Basel, 1990, pp 54-62.
41. Lethias C, Labourdette L, Willems R, Comte J, Herbage D: Composition and organization of the extracellular matrix of vein walls: Collagen networks. Int Angiol 15: 104-113, 1996.
42. Macbeath JRE, Kielty CM, Shuttleworth CA: Type VIII collagen is a product of vascular smooth-muscle cells in development and disease. Biochem J 319: 993-998, 1996.
43. Marchenko GN, Ratnikov BI, Rozanov DV, Godzik A, Deryugina EI Strogin AY: Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin. Biochem J 356: 705-718, 2001.
44. Mason DP, Kenagy RD, Hasenstab D, Bowen-Pope DF, Seifert RA, Coats S, Hawkins SM, Clowes AW: Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res 85: 1179-1185, 1999.
45. Massova I, Kotra LP, Fridman R, Mobashery S: Matrix metalloproteinases: Structures, evolution, and diversification. FASEB J 12: 1075-95, 1998.
46. Matrisian LM, Hogan BL: Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development. Curr Top Dev Biol 24: 219-259, 1990.
47. Mayne R: Collagenous proteins of blood vessels. Arteriosclerosis 6: 585-593, 1986.
48. Mrázková L, Ošťádal M, Vytášek R, Herget J: Exposure to hypoxia increases the serum levels of nitrotyrosine. Physiol Res 49: P20, 2000.
49. Muijsers RBM, Folkerts G, Henricks PA, Sadeghihashjin G, Nijkamp FP: Peroxynitrite: A two-faced metabolite of nitric oxide. Life Sci 60: 1833-1845, 1997.
50. Murphy G, Knauper V: Relating matrix metalloproteinase structure to function: Why the "hemopexin" domain? Matrix Biol 15: 511-518, 1997.
51. Murphy G, Nguyen Q, Cockett MI, Atkinson SJ, Allan JA, Knight CG, Willenbrock F, Docherty AJP: Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant. J Biol Chem 269: 6632-6636, 1994.
52. Murphy G, Stanton H, Cowell S, Butler G, Knauper V, Atkinson S, Gavrilovic J: Mechanisms for pro matrix metalloproteinase activation. APMIS 107: 38-44, 1999.
53. Nagase H: Activation mechanisms of matrix metalloproteinases. Biol Chem 378: 151-160, 1997.
54. Nagase H, Woessner JF: Matrix metalloproteinases. J Biol Chem 274: 21491-21494, 1999.
55. Nguyen M, Arkell J, Jackson CJ: Active and tissue inhibitor of matrix metalloproteinase-free gelatinase B accumulates within human microvascular endothelial vesicles. J Biol Chem 273: 5400-5404, 1998.
56. Nissen R, Cardinale GJ, Undenfriend S: Increased turnover of arterial collagen in hypertensive rats. Proc Natl Acad Sci USA 75: 451-453, 1978.
57. Novotná J, Herget J: Exposure to chronic hypoxia induces qualitative changes of collagen in the walls of peripheral pulmonary arteries. Life Sci 62: 1-12, 1998.
58. Novotná J, Herget J: Small collagen cleavage fragments present in peripheral pulmonary arteries (PPA) of rats exposed to 4 days hypoxia disappear in chronic hypoxic exposure. Physiol Res 50: P21, 2001.
59. Novotná J, Herget J, Bíbová J, Hampl V: Suppression of hypoxic pulmonary hypertension by the inhibitor of collagenolytic activity (Batimastat) in rats. Physiol Res 49: P12, 2000.
60. Novotná J, Bíbová J, Hampl V, Deyl Z, Herget J: Hyperoxia and recovery from hypoxia alter collagen in peripheral pulmonary arteries similarly. Physiol Res 50: 153-163, 2001.
61. Okamoto T, Akaike T, Nagano T, Miyajima S, Suga M, Ando M, Ichimori K, Maeda H: Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: A novel mechanism for procollagenase activation involving nitric oxide. Arch Biochem Biophys 342: 261-274, 1997a.
62. Okamoto T, Akaike T, Suga M, Maeda H, Ando M: Involvement of glutathione in activation of human matrix metalloproteinases by peroxynitrite: A novel function of glutathione in oxidative tissue injury. Am J Respir Crit Care Med 155: A187, 1997b.
63. Pei D.: Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP. J Biol Chem 274: 8925-8932, 1999.
64. Pei D, Weiss SJ: Furin-dependent intracellular activation of human stromelysin-3 zymogen. Nature 375: 244-247, 1995.
65. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS: Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. J Clin Invest 98: 2572-2579, 1996a.
66. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS: Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 98: 2572-2579, 1996b.
67. Reeves JT, Herget J: Experimental models of pulmonary hypertension. In Pulmonary Hypertension. EK Weir, JT Reeves (eds), Futura Publ. Co., New York, 1984, pp 361-391.
68. Reid LM: Structure and function in pulmonary hypertension. New perceptions. Chest 89: 279-288, 1986.
69. Riley D, Gullo J: Pressure applied to cultured pulmonary artery endothelial calls causes release of fibroblast mitogen and induces a proto-oncogene. FASEB J 2: A300, 1988.
70. Sang QX: Complex role of matrix metalloproteinases in angiogenesis. Cell Res 8: 171-177, 1998.
71. Sato H, Seiki M: Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J Biochem 119: 209-215, 1996.
72. Sato H, Kinoshita T, Takino T, Nakayama K, Seiki M: Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 393: 101-104, 1996.
73. Thakker-Varia S, Tozzi CA, Poiani GJ, Babiarz JP, Tatem L, Wilson FJ, Riley DJ: Expression of matrix-degrading enzymes in pulmonary vascular remodeling in the rat. Am J Physiol 275: L398-L406, 1998.
74. Tomásová H, Novotná J, Herget J: Mechanism of inhibition of lung collagenolytic activity by Batima stat. Physiol Res 50: P30, 2001.
75. Tozzi CA, Christiansen DL, Poiani GJ, DJR: Excess collagen in hypertensive pulmonary arteries decreases vascular distensibility. Am J Respir Crit Care Med 149: 1317-1326, 1994.
76. Tozzi CA, Thakker-Varia S, Yu SY, Bannett RF, Peng BW, Poiani GJ, Wilson FJ, Riley DJ: Mast cell collagenase correlates with regression of pulmonary vascular remodeling in the rat. Am J Respir Cell Mol Biol 18: 497-510, 1998.
77. Turto H, Lindy S, Uitto VL, Wegelius O, Uitto J: Human leucocyte collagenase: Characterization of enzyme kinetics by a new method. Anal Biochem 83: 557-569, 1977.
78. Weingarten H, Feder J: Cleavage site specificity of vertebrate collagenase. Biochem Biophys Res Commun 139: 1184-1187, 1986.
79. Wilhelm J, Herget J: Free radicals in rat lung during and after hypoxia. Physiol Res 48: 53P, 1999.
80. Wilhelm J, Vaňková M, Maxová H, Šišková A: On the role of hydrogen peroxide in hypoxic lung free radical damage. Physiol Res (Submitted) 2002.
81. Willenbrock F, Crabbe T, Slocombe PM, Sutton CW, Docherty AJ, Cockett MI, O'Shea M, Brocklehurst K, Phillips IR, Murphy G: The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: A kinetic analysis of the inhibition of gelatinase A. Biochemistry 32: 4330-4337, 1993.
82. Williamson RA, Muskett FW, Howard MJ, Freedman RB, Carr MD: The effect of matrix metalloproteinase complex formation on the conformational mobility of tissue inhibitor of metalloproteinases-2(TIMP-2). J Biol Chem 274: 37226-37232, 1999.
83. Zempo N, Kenagy RD, Au YP, Bendeck M, Clowes MM, Reidy MA, Clowes AW: Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. J Vasc Surg 20: 209-217, 1994.